Su Jin Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Su Jin Park has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Gwang Ha Kim
Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea
4 shared publications - Moon Won Lee
Division of Gastroenterology, Pusan National University Hospital, Busan, Korea
4 shared publications - Bong Eun Lee
Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
3 shared publications - Hoseok I.
Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea
2 shared publications - Chae Hwa Kwon
BioMedical Research Institute, Pusan National University Hospital, Busan, Korea
1 shared publication - Dong Chan Joo
Division of Gastroenterology, Pusan National University Hospital, Busan, Korea
1 shared publication
Latest Publications
- Open Access
- 29 June 2026
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (5) , 745-755
Proteomic Analysis of Extracellular Vesicles Reveals Vitronectin and Laminin Subunit Alpha-3 as Candidate Biomarkers for Gastric Cancer
Clinically useful noninvasive biomarkers for gastric cancer remain limited. Extracellular vesicles (EVs) carry a molecular cargo reflective of their cells of origin and have emerged as promising candidates for blood-based cancer biomarkers. We aimed to identify EV-associated protein biomarkers for gastric cancer via a proteomic approach. Proteomic profiling of EVs was performed using one normal gastric cell line (Hs738st/int) and two gastric cancer cell lines (AGS and NCI-N87). Selected proteins were validated in blood-derived EVs isolated from plasma samples of 10 healthy controls and 36 patients with gastric cancer. Proteomic analysis identified 224 differentially expressed proteins whose expression was consistently altered in gastric cancer cell line-derived EVs. Among these, vitronectin (VTN) and laminin subunit alpha-3 (LAMA3) were selected based on their consistent upregulation. EV-associated LAMA3 levels were significantly higher in patients with gastric cancer than in healthy controls (p=0.003), with significant elevations observed from stage II onward (p=0.041, p=0.017, and p=0.004 for stages II, III, and IV, respectively). EV-associated VTN levels were not significantly different overall (p=0.089); however, stage-specific analysis demonstrated significant increases in VTN levels in patients with stage III (p=0.036) and stage IV (p=0.005) gastric cancer. Both EV-associated VTN and LAMA3 levels showed significant positive correlations with the cancer stage (ρ=0.564 and ρ=0.611, respectively; both p<0.001). The levels of EV-associated VTN and LAMA3 appear to be more closely associated with disease progression than with early-stage detection of gastric cancer. These findings suggest that EV-based proteomic biomarkers may have clinical utility for monitoring tumor progression in patients with clinically advanced gastric cancer.
- 29 June 2026
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (5) , 745-755
Open AccessProteomic Analysis of Extracellular Vesicles Reveals Vitronectin and Laminin Subunit Alpha-3 as Candidate Biomarkers for Gastric Cancer
Clinically useful noninvasive biomarkers for gastric cancer remain limited. Extracellular vesicles (EVs) carry a molecular cargo reflective of their cells of origin and have emerged as promising candidates for blood-based cancer biomarkers. We aimed to identify EV-associated protein biomarkers for gastric cancer via a proteomic approach. Proteomic profiling of EVs was performed using one normal gastric cell line (Hs738st/int) and two gastric cancer cell lines (AGS and NCI-N87). Selected proteins were validated in blood-derived EVs isolated from plasma samples of 10 healthy controls and 36 patients with gastric cancer. Proteomic analysis identified 224 differentially expressed proteins whose expression was consistently altered in gastric cancer cell line-derived EVs. Among these, vitronectin (VTN) and laminin subunit alpha-3 (LAMA3) were selected based on their consistent upregulation. EV-associated LAMA3 levels were significantly higher in patients with gastric cancer than in healthy controls (p=0.003), with significant elevations observed from stage II onward (p=0.041, p=0.017, and p=0.004 for stages II, III, and IV, respectively). EV-associated VTN levels were not significantly different overall (p=0.089); however, stage-specific analysis demonstrated significant increases in VTN levels in patients with stage III (p=0.036) and stage IV (p=0.005) gastric cancer. Both EV-associated VTN and LAMA3 levels showed significant positive correlations with the cancer stage (ρ=0.564 and ρ=0.611, respectively; both p<0.001). The levels of EV-associated VTN and LAMA3 appear to be more closely associated with disease progression than with early-stage detection of gastric cancer. These findings suggest that EV-based proteomic biomarkers may have clinical utility for monitoring tumor progression in patients with clinically advanced gastric cancer.
- Open Access
- 1 January 2022
- Published by XMLink in Journal of Korean Medical Science
- Vol. 37 (24) , e197
MicroRNA Expression in Plasma of Esophageal Squamous Cell Carcinoma Patients
Kahng DH, et al. J Korean Med Sci. 2022 Jun;37(24):e197. https://doi.org/10.3346/jkms.2022.37.e197
- 1 January 2022
- Published by XMLink in Journal of Korean Medical Science
- Vol. 37 (24) , e197
Open AccessMicroRNA Expression in Plasma of Esophageal Squamous Cell Carcinoma Patients
Kahng DH, et al. J Korean Med Sci. 2022 Jun;37(24):e197. https://doi.org/10.3346/jkms.2022.37.e197
- Open Access
- 15 July 2021
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 15 (4) , 553-561
Clinical Significance of TWIST-Positive Circulating Tumor Cells in Patients with Esophageal Squamous Cell Carcinoma
Hyun Jung Lee, Gwang Ha Kim, Su Jin Park, Chae Hwa Kwon, Moon Won Lee, Bong Eun Lee, Dong Hoon Baek, and Hoseok I. Gut and Liver 2021;15:553-61. https://doi.org/10.5009/gnl20194
- 15 July 2021
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 15 (4) , 553-561
Open AccessClinical Significance of TWIST-Positive Circulating Tumor Cells in Patients with Esophageal Squamous Cell Carcinoma
Hyun Jung Lee, Gwang Ha Kim, Su Jin Park, Chae Hwa Kwon, Moon Won Lee, Bong Eun Lee, Dong Hoon Baek, and Hoseok I. Gut and Liver 2021;15:553-61. https://doi.org/10.5009/gnl20194
- Open Access
- 17 April 2019
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 13 (4) , 394-401
Clinical Application of Circulating Tumor Cells in Gastric Cancer
Moon Won Lee, Gwang Ha Kim, Hye Kyung Jeon, and Su Jin Park. Gut and Liver 1999;0:. https://doi.org/10.5009/gnl18484
- 17 April 2019
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 13 (4) , 394-401
Open AccessClinical Application of Circulating Tumor Cells in Gastric Cancer
Moon Won Lee, Gwang Ha Kim, Hye Kyung Jeon, and Su Jin Park. Gut and Liver 1999;0:. https://doi.org/10.5009/gnl18484